| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/11/1996 | EP0730471A1 Use of lithium compounds in the treatment of cardiac insufficiency |
| 09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
| 09/11/1996 | EP0730469A1 Modified truncated complement system regulators |
| 09/11/1996 | EP0730468A1 Medicinal activity of aspartame |
| 09/11/1996 | EP0730467A1 Inhibitors of farnesyl-protein transferase |
| 09/11/1996 | EP0730466A1 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites |
| 09/11/1996 | EP0730465A1 Use of angiotensin iii and analogs thereof in tissue repair |
| 09/11/1996 | EP0730454A1 Antiarrhythmic benzodiazepines |
| 09/11/1996 | EP0730448A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor |
| 09/11/1996 | EP0591392B1 Pharmaceutical formulations of osteogenic proteins |
| 09/11/1996 | EP0540574B1 Anticoagulant peptides |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | EP0531537B1 Hirudin analogue or salt thereof, production thereof, and anticoagulant containing the same as active ingredient |
| 09/11/1996 | EP0528903B1 Methods of preventing viral replication |
| 09/11/1996 | EP0484401B1 Production of vascular endothelial cell growth factor |
| 09/11/1996 | EP0453453B1 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 09/11/1996 | EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 09/11/1996 | EP0366710B1 Growth hormone receptor |
| 09/11/1996 | CN1130911A Multiple branch peptide constructions for use against HIV |
| 09/11/1996 | CN1130898A Difluoro statone antiviral analogs |
| 09/11/1996 | CN1130866A Anti-angiogenic compositions and method of use |
| 09/11/1996 | CN1130684A Recombination double-cistron expressing plasmid, and its preparing process and use |
| 09/11/1996 | CN1130532A Modulation of cellular activity |
| 09/11/1996 | CA2171403A1 .alpha. substituted-1-benzyl-naphthyls |
| 09/10/1996 | US5554783 (2r, 3r, 4s, 5s)-3-acetoxy-2,5-bis/benzyloxycarbonylamino/ -4-bromo-1,5-diphenylhexane |
| 09/10/1996 | US5554756 Amino acid derivatives |
| 09/10/1996 | US5554728 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 09/10/1996 | US5554727 Anti-obesity proteins |
| 09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 09/10/1996 | US5554644 Tachykinin (NK2) antagonists |
| 09/10/1996 | US5554643 Pro-drugs for CCK antagonists |
| 09/10/1996 | US5554641 Nonpeptides as tachykinin antagonists |
| 09/10/1996 | US5554638 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 09/10/1996 | US5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates |
| 09/10/1996 | US5554595 Selective regulation of B lymphocyte precursors by hormones |
| 09/10/1996 | US5554594 Imidazolidine derivatives |
| 09/10/1996 | US5554593 Therapeutic agent for threatened abortion |
| 09/10/1996 | US5554590 Contacting asthma reversal factor to respiratory epithelium of subject |
| 09/10/1996 | US5554528 Compositions and methods for inhibition of HIV production |
| 09/10/1996 | US5554526 Human parainfluenza virus type 4A fusion protein and gene coding for the same |
| 09/10/1996 | US5554515 Immunizing a non-human warm blooded animal with purifiedantigen; recovering an antibody producing cell; fusion of this cell to produce hybrid |
| 09/10/1996 | US5554514 Production of recombinant human interferon beta2.sbsb.B |
| 09/10/1996 | US5554513 Production of recombinant human interferon-beta2 |
| 09/10/1996 | US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences |
| 09/10/1996 | US5554511 Calcium independent cytosolic phospholipase A2 /B enzymes |
| 09/10/1996 | US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 09/10/1996 | US5554501 Genetic analysis of patient samples |
| 09/10/1996 | US5554500 Cloned genes for human dopamine D2 receptors and cell lines expressing same |
| 09/10/1996 | US5554499 Detection and isolation of ligands |
| 09/10/1996 | US5554382 Critical fluids |
| 09/10/1996 | US5554378 Pharmaceutical composition and its mucosal use |
| 09/10/1996 | US5554375 Hair growth |
| 09/10/1996 | US5554366 Skin care method and composition |
| 09/10/1996 | US5554150 Granulocyte colony-stimulating factor solution delivery method |
| 09/10/1996 | CA2171242A1 Msrv-1 virus and pathogenic and/or infective msrv-2 related to rhumatoid arthritis |
| 09/06/1996 | WO1996027131A1 Anti dna antibody detection involving telomeric dna sequence recognition and binding |
| 09/06/1996 | WO1996027020A1 Atherosclerosis gene therapy using monocyte line hdl production |
| 09/06/1996 | WO1996027019A1 Transgenic animals as model of psoriasis |
| 09/06/1996 | WO1996027018A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
| 09/06/1996 | WO1996027017A1 A method for expressing modified recombinant proteins in a bacterial system |
| 09/06/1996 | WO1996027011A1 A method for making heteromultimeric polypeptides |
| 09/06/1996 | WO1996027010A1 Murine/human chimeric monoclonal antibody or a fragment thereof specific for the egf receptor |
| 09/06/1996 | WO1996027009A1 Human amine transporter |
| 09/06/1996 | WO1996027008A2 Agent for treating tumours and other hyperplasia |
| 09/06/1996 | WO1996027007A1 A novel growth factor and a genetic sequence encoding same |
| 09/06/1996 | WO1996027006A2 Human vegf-specific antisense oligonucleotides |
| 09/06/1996 | WO1996027005A2 Recombinant dna molecules that code for polypeptides with antigenic properties of allergens clah8 and clah12 |
| 09/06/1996 | WO1996026964A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 09/06/1996 | WO1996026962A1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 09/06/1996 | WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | WO1996026960A1 Fish basic fibroblast growth factor, dna and use of the same |
| 09/06/1996 | WO1996026958A2 Eph RECEPTOR LIGAND ELF-2 |
| 09/06/1996 | WO1996026956A1 Protein phosphatase inhibitor |
| 09/06/1996 | WO1996026955A1 Peptide and a method of obtaining it |
| 09/06/1996 | WO1996026954A1 FsF-1 AND THE EARLY DETECTION OF FIBROSIS |
| 09/06/1996 | WO1996026953A1 FsF-1 AND THE EARLY DETECTION OF FIBROSIS |
| 09/06/1996 | WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 09/06/1996 | WO1996026744A1 Dna encoding natural killer lytic associated protein |
| 09/06/1996 | WO1996026742A1 Gene transfer-mediated angiogenesis therapy |
| 09/06/1996 | WO1996026739A1 Use of protealytic enzymes in the treatment of insect bites |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026737A1 Morphogen-induced dentine regeneration |
| 09/06/1996 | WO1996026736A1 Vascular endothelial growth factor-b |
| 09/06/1996 | WO1996026735A1 Method for stimulating an immune response |
| 09/06/1996 | WO1996026734A1 Antiviral combinations of bch-189 and ritonavir |
| 09/06/1996 | WO1996026733A1 Codominance-mediated toxins |
| 09/06/1996 | WO1996026731A1 Use of magnesium vanadate for the treatment of insulin resistance syndrome |
| 09/06/1996 | WO1996026716A1 Elcatonin controlled release microsphere formulation for treatment of osteoporosis |
| 09/06/1996 | WO1996022305A3 Modified peptides |
| 09/06/1996 | WO1996021655A3 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 09/06/1996 | WO1996021015A3 Combination gene delivery vehicles |
| 09/06/1996 | WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 09/06/1996 | WO1996020954A3 Functionally active domains of signal transducer and activators of transcription (STAT) proteins |
| 09/06/1996 | WO1996020688A3 Triggered pore-forming agents |
| 09/06/1996 | WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 09/06/1996 | WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/06/1996 | WO1996018646A3 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
| 09/06/1996 | WO1996017934A3 Cloning and recombinant production of crf receptor(s) |
| 09/06/1996 | WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/06/1996 | CA2248177A1 Use of protealytic enzymes in the treatment of insect bites |